Nada Al-Antary,Kelly A Hirko,Andrea E Cassidy-Bushrow,Katie R Zarins,Mike J Simoff,Thomas Song,Avi Cohen,Christine Neslund-Dudas
{"title":"Coronary Artery Calcification Identified on Lung Cancer Screening CT Scans: A Scoping Review.","authors":"Nada Al-Antary,Kelly A Hirko,Andrea E Cassidy-Bushrow,Katie R Zarins,Mike J Simoff,Thomas Song,Avi Cohen,Christine Neslund-Dudas","doi":"10.1016/j.chest.2025.03.031","DOIUrl":null,"url":null,"abstract":"TOPIC IMPORTANCE\r\nCoronary artery calcification (CAC) can be a significant incidental finding on low-dose computed tomography (CT) scans performed for lung cancer screening (LCS). CAC presence and grade hold important diagnostic, and preventive value, particularly in patients without previously recognized coronary artery disease. This scoping review describes the prevalence of CAC as an incidental finding on LCS CT scans across prior studies and identifies directions for future research.\r\n\r\nREVIEW FINDINGS\r\nThe initial search resulted in 256 abstracts screened for eligibility, resulting in 32 articles included in the final review. CAC presence across included studies varied from 14.8% to 98%. CAC was most commonly reported as mild in grade, among 46.9% of studies. The majority of studies were conducted among predominantly White male participants. Finally, only 6 articles provided information on down-stream interventions for patients with newly detected CAC.\r\n\r\nSUMMARY\r\nCAC, a predictive risk factor for cardiovascular events and mortality, is a frequently detected incidental finding on LCS CT scans, with substantial variation in presence across studies. Identification of CAC on LCS CT could inform clinical decisions to reduce patients' overall cardiovascular risk. These findings underscore the significance of standardizing the documentation and management of CAC in LCS. Finally, future studies should include greater race diversity.","PeriodicalId":9782,"journal":{"name":"Chest","volume":"18 1","pages":""},"PeriodicalIF":9.5000,"publicationDate":"2025-04-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chest","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.chest.2025.03.031","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CRITICAL CARE MEDICINE","Score":null,"Total":0}
引用次数: 0
Abstract
TOPIC IMPORTANCE
Coronary artery calcification (CAC) can be a significant incidental finding on low-dose computed tomography (CT) scans performed for lung cancer screening (LCS). CAC presence and grade hold important diagnostic, and preventive value, particularly in patients without previously recognized coronary artery disease. This scoping review describes the prevalence of CAC as an incidental finding on LCS CT scans across prior studies and identifies directions for future research.
REVIEW FINDINGS
The initial search resulted in 256 abstracts screened for eligibility, resulting in 32 articles included in the final review. CAC presence across included studies varied from 14.8% to 98%. CAC was most commonly reported as mild in grade, among 46.9% of studies. The majority of studies were conducted among predominantly White male participants. Finally, only 6 articles provided information on down-stream interventions for patients with newly detected CAC.
SUMMARY
CAC, a predictive risk factor for cardiovascular events and mortality, is a frequently detected incidental finding on LCS CT scans, with substantial variation in presence across studies. Identification of CAC on LCS CT could inform clinical decisions to reduce patients' overall cardiovascular risk. These findings underscore the significance of standardizing the documentation and management of CAC in LCS. Finally, future studies should include greater race diversity.
期刊介绍:
At CHEST, our mission is to revolutionize patient care through the collaboration of multidisciplinary clinicians in the fields of pulmonary, critical care, and sleep medicine. We achieve this by publishing cutting-edge clinical research that addresses current challenges and brings forth future advancements. To enhance understanding in a rapidly evolving field, CHEST also features review articles, commentaries, and facilitates discussions on emerging controversies. We place great emphasis on scientific rigor, employing a rigorous peer review process, and ensuring all accepted content is published online within two weeks.